ProTrading24ru

Moderna nears FDA approval - what's next?

NASDAQ:MRNA   Moderna, Inc.
#MRNA got a positive report of FDA expert commission on its covid vaccine today.
Committee meeting is scheduled for Thursday and vaccine approval may be granted starting from Friday.

It's going to be the most expensive vaccine of all so the sale numbers won't be of a global scale.

Way up to $200 for the #MRNA stock is technically pathed through the correction at $140.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.